Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model

J.M. Fernández Gómez, Rosário Madero, Eduardo Solsona, +16

The Journal of Urology

Prognostic Factors in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Multivariate Analysis of Data from Four Randomized CUETO Trials

J.M. Fernández Gómez, Eduardo Solsona, Miguel Unda, +16

European Urology

Prognostic FactorsUrologyBacillus Calmette-guérinUrologic Cancer EpidemiologyGenitourinary Cancer +7

A Multicentre, Randomised Prospective Trial Comparing Three Intravesical Adjuvant Therapies for Intermediate-Risk Superficial Bladder Cancer: Low-Dose Bacillus Calmette-Guerin (27 mg) versus Very Low-Dose Bacillus Calmette-Guerin (13.5 mg) versus Mitomycin C

Antonio Ojea, José Luís Nogueira, Eduardo Solsona, +11

European Urology

UrologySurgical OncologyGenitourinary CancerMedicineVersus Mitomycin C +4

The EORTC Tables Overestimate the Risk of Recurrence and Progression in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: External Validation of the EORTC Risk Tables

J.M. Fernández Gómez, Rosário Madero, Eduardo Solsona, +16

European Urology

External ValidationSurgical OncologyUrologyCancer EpidemiologyUrologic Cancer Epidemiology +12

Maintenance Therapy with 3-monthly Bacillus Calmette-Guérin for 3 Years is Not Superior to Standard Induction Therapy in High-risk Non–muscle-invasive Urothelial Bladder Carcinoma: Final Results of Randomised CUETO Study 98013

Luis Martínez‐Piñeiro, José Antonio Portillo, J.M. Fernández Gómez, +18

European Urology

Urological ResearchSurgical OncologyUrologyUrologic Cancer EpidemiologyGenitourinary Cancer +6

Sequential Combination of Mitomycin C Plus Bacillus Calmette-Guérin (BCG) Is More Effective but More Toxic Than BCG Alone in Patients with Non–Muscle-invasive Bladder Cancer in Intermediate- and High-risk Patients: Final Outcome of CUETO 93009, a Randomized Prospective Trial

Eduardo Solsona, Rosário Madero, V. Chantada, +15

European Urology

Surgical OncologyUrologyGenitourinary CancerSequential CombinationMedicine +5

Treatment of male stress urinary incontinence with the adjustable transobturator male system: Outcomes of a multi‐center Iberian study

J.C. Angulo, Francisco Cruz, Cristina Esquinas, +15

Neurourology and Urodynamics

Long‐term outcome of adjustable transobturator male system for stress urinary incontinence in the Iberian multicentre study

J.C. Angulo, Miguel Vírseda Chamorro, I. Arance, +13

Neurourology and Urodynamics

Lifestyle factors and oncogenic papillomavirus infection in a high-risk male population

E. López-Díez, Sonia Pérez‐Castro, Manuel Carballo, +9

PLoS ONE

Patient satisfaction with adjustable transobturator male system in the Iberian multicenter study

J.C. Angulo, I. Arance, Antonio Ojea, +9

World Journal of Urology

Gross AnatomyGender Affirming SurgeryRehabilitationSurgeryIberian Multicenter Study +2